🇺🇸 FDA
Pipeline program

Riluzole Oral Soluble Film

17MO1R-0016

Phase 2 small_molecule terminated

Quick answer

Riluzole Oral Soluble Film for ALS is a Phase 2 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Aquestive Therapeutics
Indication
ALS
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials